Opioid-Induced Constipation Treatment Market Size:

“The Global Opioid-Induced Constipation Treatment Market was valued around US$ 3.8 Bn by 2018 and growing at a significant CAGR over next seven years 2019-2025 due to increasing awareness about availability of opioids”

Opioid-Induced Constipation Treatment Market Growth Drivers and Restraints:

The global opioid-induced constipation treatment market accounted for US$ 3.8 Bn in 2018 and burgeoning over the forthcoming years. Advances in pharmaceutical industry in the past few years, increasing awareness about availability of opioids, increasing number of people consuming opioids in the form of recreational drugs, increasing awareness about availability of a wide range of opioid medicines and rising approval rate of pipeline drugs are some key factors favoring the market growth. However, factors such as lack of awareness regarding forthcoming innovative treatments and high costs are hampering the market growth.

Browse More Insights of the report @ https://www.precisionbusinessinsights.com/market-reports/global-opioid-induced-constipation-treatment-market/

Locally Acting Chloride Channel Activators dominate the Global Opioid-Induced Constipation Treatment Market

Based on drug type, global opioid-induced constipation treatment market is segmented into peripherally restricted μ-opioid receptor antagonists, non-selective opioid antagonists, μ -opioid receptor antagonists and locally acting chloride channel activators. Locally acting chloride channel activators held considerable market growth during estimated period. A locally acting type-2 chloride channel activator, brings intestinal fluid secretion. To measure effectiveness and protection of oral lubiprostone at many doses for the treatment of chronic constipation.

North America Leads the Global Opioid-Induced Constipation Treatment market

PBI’s global opioid-induced constipation treatment market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. North America accounted for larger revenue share in global opioid-induced constipation treatment market with considerable CAGR. The growth in this region is due to existence of large percentage of population that consumes opioid drugs. Also, U.S is the major contributor for the growth of the market in this region.

Strategic Approvals are the key strategies adopted by market players

Global opioid-induced constipation treatment market further reveals that the key players increasingly accepting strategies such as approvals of the new products, launch of newer products, recurrent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the regions. For Instance, In March 2017, FDA approved Symphonic (Naldemedine) for the treatment of Opioid-Induced Constipation, which was manufactured by Purdue Pharma LP and Shionogi

Key player’s profiles in the report are GlaxoSmithKline plc (U.K.), AstraZeneca U.K), Pfizer Inc. (U.S.), SLA Pharma AG (U.K.), AIKO Biotechnology, Inc. (U.S.), Cubist Pharmaceuticals (Merck & Co.) (U.S.), Takeda Pharmaceutical Company Limited (Japan), Boehringer Ingelheim GmbH (Germany), Bayer AG (Germany), Valeant Pharmaceuticals International Inc. (Canada), Abbott Laboratories (U.S.), Purdue Pharma LP (U.S.) Shionogi Inc. (U.S.) and Cosmo Pharmaceuticals N.V. (Ireland).

Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=16265

Detailed Segmentation of Opioid-Induced Constipation Treatment Market:

By Drug Type
o Peripherally restricted μ-opioid receptor antagonists
o Non-selective opioid antagonists
o μ -opioid receptor antagonists
o Locally acting chloride channel activators

By Formulation Type
o Solids
o Semi-solids
o Liquids

By Route of Administration
o Oral
o Parenteral (Subcutaneous Injection)

By Distribution Channel
o Drugstore
o Retail pharmacies
o Hospital pharmacies

By Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights